Copyright
©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 102064
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102064
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102064
Table 1 Advantages and disadvantages of proactive pharmacologic strategy for Crohn’s disease patient post-ileocecal resection, and proposed qualification criteria
Qualification criteria | Advantages | Disadvantages |
History of multiple bowel resections | Lower risk of disease recurrence | Higher cost |
Perianal involvement | Lower risk of disease-related complications | Risk of overtreatment |
Penetrating disease behavior | ||
Patients under 30 years old | ||
Smokers | ||
Presence of granulomas in resection specimen | ||
Presence of myenteric plexitis |
Table 2 Detailed description of REMIND score according to Hammoudi et al[54]
REMIND score | |
Anastomotic lesions (< 1 cm in length after the anastomosis) | |
A(0) | No lesion |
A(1) | Ulcerations covering less than 50% of the anastomosis circumference |
A(2) | Ulcerations covering more than 50% of the anastomosis circumference |
A(3) | Anastomotic stenosis |
Ileal lesions | |
I(0) | No lesion |
I(1) | ≤ 5 aphthous ulcers |
I(2) | > 5 aphthous lesions with normal intervening mucosa or skip areas of larger lesions |
I(3) | Diffuse aphthous ileitis with diffusely inflamed mucosa |
I(4) | Diffuse inflammation with larger ulcers |
- Citation: Cwaliński J, Stawczyk-Eder K, Cwalinska A, Zasada W, Cholerzyńska H, Banasiewicz T, Paszkowski J. Insufficiency of ileocolic anastomosis in Crohn’s disease patients – prevention and treatment. World J Gastrointest Surg 2025; 17(5): 102064
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/102064.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.102064